The role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health

In conjunction with advancements in modern medicine, bone health is becoming an increasingly prevalent concern among a global population with an ever-growing life expectancy. Countless factors contribute to declining bone strength, and age exacerbates nearly all of them. The detrimental effects of b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carlie Priddy, Jiliang Li
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/db617873a2734cf2ac6ef5e0b4addb67
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:db617873a2734cf2ac6ef5e0b4addb67
record_format dspace
spelling oai:doaj.org-article:db617873a2734cf2ac6ef5e0b4addb672021-11-24T04:31:26ZThe role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health2352-187210.1016/j.bonr.2021.101149https://doaj.org/article/db617873a2734cf2ac6ef5e0b4addb672021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S235218722100406Xhttps://doaj.org/toc/2352-1872In conjunction with advancements in modern medicine, bone health is becoming an increasingly prevalent concern among a global population with an ever-growing life expectancy. Countless factors contribute to declining bone strength, and age exacerbates nearly all of them. The detrimental effects of bone loss have a profound impact on quality of life. As such, there is a great need for full exploration of potential therapeutic targets that may provide antiaging benefits and increase the life and strength of bone tissues. The Keap1-Nrf2 pathway is a promising avenue of this research. The cytoprotective and antioxidant functions of this pathway have been shown to mitigate the deleterious effects of oxidative stress on bone tissues, but the exact cellular and molecular mechanisms by which this occurs are not yet fully understood. Presently, refined animal and loading models are allowing exploration into the effect of the Keap1-Nrf2 pathway in a tissue-specific or even cell-specific manner. In addition, Nrf2 activators currently undergoing clinical trials can be utilized to investigate the particular cellular mechanisms at work in this cytoprotective cascade. Although the timing and dosing of treatment with Nrf2 activators need to be further investigated, these activators have great potential to be used clinically to prevent and treat osteoporosis.Carlie PriddyJiliang LiElsevierarticleNrf2Keap1OsteoporosisMechanobiologyAntioxidantsDiseases of the musculoskeletal systemRC925-935ENBone Reports, Vol 15, Iss , Pp 101149- (2021)
institution DOAJ
collection DOAJ
language EN
topic Nrf2
Keap1
Osteoporosis
Mechanobiology
Antioxidants
Diseases of the musculoskeletal system
RC925-935
spellingShingle Nrf2
Keap1
Osteoporosis
Mechanobiology
Antioxidants
Diseases of the musculoskeletal system
RC925-935
Carlie Priddy
Jiliang Li
The role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health
description In conjunction with advancements in modern medicine, bone health is becoming an increasingly prevalent concern among a global population with an ever-growing life expectancy. Countless factors contribute to declining bone strength, and age exacerbates nearly all of them. The detrimental effects of bone loss have a profound impact on quality of life. As such, there is a great need for full exploration of potential therapeutic targets that may provide antiaging benefits and increase the life and strength of bone tissues. The Keap1-Nrf2 pathway is a promising avenue of this research. The cytoprotective and antioxidant functions of this pathway have been shown to mitigate the deleterious effects of oxidative stress on bone tissues, but the exact cellular and molecular mechanisms by which this occurs are not yet fully understood. Presently, refined animal and loading models are allowing exploration into the effect of the Keap1-Nrf2 pathway in a tissue-specific or even cell-specific manner. In addition, Nrf2 activators currently undergoing clinical trials can be utilized to investigate the particular cellular mechanisms at work in this cytoprotective cascade. Although the timing and dosing of treatment with Nrf2 activators need to be further investigated, these activators have great potential to be used clinically to prevent and treat osteoporosis.
format article
author Carlie Priddy
Jiliang Li
author_facet Carlie Priddy
Jiliang Li
author_sort Carlie Priddy
title The role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health
title_short The role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health
title_full The role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health
title_fullStr The role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health
title_full_unstemmed The role of the Nrf2/Keap1 signaling cascade in mechanobiology and bone health
title_sort role of the nrf2/keap1 signaling cascade in mechanobiology and bone health
publisher Elsevier
publishDate 2021
url https://doaj.org/article/db617873a2734cf2ac6ef5e0b4addb67
work_keys_str_mv AT carliepriddy theroleofthenrf2keap1signalingcascadeinmechanobiologyandbonehealth
AT jiliangli theroleofthenrf2keap1signalingcascadeinmechanobiologyandbonehealth
AT carliepriddy roleofthenrf2keap1signalingcascadeinmechanobiologyandbonehealth
AT jiliangli roleofthenrf2keap1signalingcascadeinmechanobiologyandbonehealth
_version_ 1718416005586223104